Venous Distension in Patients With Aneurysmatic Arterial Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02867501|
Recruitment Status : Completed
First Posted : August 16, 2016
Last Update Posted : April 4, 2017
Kantonsspital Baselland Bruderholz
Information provided by (Responsible Party):
Janis Christian Bartelt, Kantonsspital Baselland Bruderholz
The aim of the study is to assess if venous distension in patients with aneurysmatic arteriopathy is higher compared to patients with peripheral arterial occlusive disease (PAOD) and in controls.
|Condition or disease|
|Aortic Aneurysm, Abdominal Popliteal Artery Aneurysm Peripheral Arterial Occlusive Disease Vascular Diseases Aortic Diseases Varicose Veins|
Patients with aortic aneurysm and patients with PAOD and Controls will be investigated in the following manner: Duplexsonography with assessment of the arterial diameters in the aorta and leg arteries. Duplexsonography with assessment of venous reflux in proximal and deep veins of both legs Duplexsonography testing of venous distension in the common femoral vein, the great saphenous vein and the femoral vein.
|Study Type :||Observational|
|Actual Enrollment :||98 participants|
|Official Title:||Venous Distension in Patients With Aneurysmatic Arterial Disease Compared to the Venous Distension in Patients With Arterial Occlusive Disease|
|Study Start Date :||May 2016|
|Actual Primary Completion Date :||March 28, 2017|
|Actual Study Completion Date :||March 28, 2017|
Patients with dilatative arteriopathy (DA) the aortic diameter must be > 3 cm or the popliteal artery diameter > 1.5 cm
Peripheral arterial occlusive disease
Patients with arterial occlusive disease (PAOD) defined with an Ankle brachial index (ABI) < 0.9 and positive criteria in the Edinburgh questionnaire.
Control group of age matched persons without PAOD (ABI > 0.9) and without DA.
Primary Outcome Measures :
- Venous distension of > 27% in patients with aneurysmatic arterial disease [ Time Frame: one year ]
No Contacts or Locations Provided